Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
The "Hair Count" Human Trial (2018) In a rigorous 6-month human trial, researchers evaluated the efficacy of a GHK-peptide complex (the primary active component of copper peptides) against a placebo
Unlike regular anti-inflammatory drugs, BPC-157 works in multiple ways without known harmful side effects
Additionally, it is advisable to avoid excessive caffeine consumption
Instead, the research suggests it orchestrates the body's own repair mechanisms, making them faster and more efficient
From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
PMCID: PMC12263609.
US$ 29.39
US$ 28.34
US$ 25.18
US$ 29.21
US$ 21.55